Skip to main content

Advertisement

Table 3 Investigations ordered in the ED

From: The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania

  Overall Died Survived Relative risk P-value
n/N (%) n/N (%) n/N (%) RR (95%CI)
Laboratory Tests
 WBC Ω (> 11 K/uL) 346/656 (52.7) 11/16 (68.8) 335/640 (52.3) 2.0 (0.7–5.6) 0.2
 Haemoglobin (< 7 g/dL) 342/656 (52.1) 16/16 (100) 326/640 (50.9) 30.3 (1.8–503) 0.02
 Abnormal urine results δ 11/63 (17.5) 1/16 (6.3) 10/47 (21.3) 0.3 (0.04–2.11) 0.2
 Malaria test positive 48/415 (11.6) 12/16 (75) 36/399 (9.0) 22.9 (7.7–68) < 0.0001
 Elevated RFTβ 24/219 (11.0) 9/16 (56.3) 15/203 (7.4) 10.4 (4.2–25.5) < 0.0001
 Low RBGη (< 3 mmol/L) 39/627 (6.2) 12/16 (75) 27/611 (4.4) 45.2 (15.3–133.8) < 0.0001
Imaging Tests
 Abnormal chest x-ray α 30/85 (35.3) 11/16 (68.8) 19/69 (27.5) 4.0 (1.5–10.5) 0.004
 Abnormal brain CT scan ρ 7/26 (26.9) 5/16 (31.3) 2/10 (20) 1.2 (0.67–2.2) 0.5
  1. Ω WBC-White Blood Cell
  2. δ Presence of blood in urine, leukocytes, nitrites, albumin, or glucose
  3. α Signs of infection or stroke
  4. β RFT-Renal function test
  5. η RBG-Random Blood Glucose
  6. α Pneumonic changes
  7. ρ Signs of stroke